Shawn Marcell

Shawn Marcell Email and Phone Number

Cambridge, MA, US
Shawn Marcell's Location
Cambridge, Massachusetts, United States, United States
About Shawn Marcell

Shawn Marcell has 30 years of executive experience leading interdisciplinary teams in technology and the life sciences. His background includes venture creation, growth acceleration and raising more than $400M in capital for private and public companies. Shawn has founded and chaired several early stage venture-backed companies in the life sciences including ReadCoor (acquired by 10X Genomics), DropWorks (acquired by BioRad), RedPoint Bio (public in 2005), SensiGen (acquired by Sequenom), Lifecodes (division of Hologic acquired by Immucor), and Metamark Genetics (acquired by LabCorp). In addition to launching multiple startups, Shawn’s leadership experience includes large corporations, academic institutions and venture capital funds.

Shawn Marcell's Current Company Details
Hansjorg Wyss Institute for Biologically Inspired Engineering, Harvard Universit

Hansjorg Wyss Institute For Biologically Inspired Engineering, Harvard Universit

View
Visiting Scholar and Entrepreneur-in-Residence
Cambridge, MA, US
Shawn Marcell Work Experience Details
  • Hansjorg Wyss Institute For Biologically Inspired Engineering, Harvard Universit
    Visiting Scholar And Entrepreneur-In-Residence
    Hansjorg Wyss Institute For Biologically Inspired Engineering, Harvard Universit
    Cambridge, Ma, Us
  • Sempresto, Inc
    Executive Chairman, Co-Founder
    Sempresto, Inc Jun 2023 - Present
  • Bifrost Biosystems
    Executive Chairman, Co-Founder
    Bifrost Biosystems Oct 2021 - Present
    Bifrost Biosystems, a recent spinout from Harvard Medical School, has developed and is commercializing a leading platform for high throughput multi-generational single cell imaging, retrieval and genotyping.
  • Aixmed, Inc.
    Member, Board Of Directors; Advisor
    Aixmed, Inc. Mar 2020 - Present
    Santa Clara, California, Us
    AIxMed is an AI powered platform combining advanced machine learning and computer vision to discover deep insights in cytology samples.
  • Hansjorg Wyss Institute For Biologically Inspired Engineering, Harvard University
    Visiting Scholar/Entrepreneur-In-Residence
    Hansjorg Wyss Institute For Biologically Inspired Engineering, Harvard University Oct 2019 - Present
  • Monell Chemical Senses Center
    Member Of The Board Of Directors; Chairman - International Advisory Council
    Monell Chemical Senses Center Jan 2012 - Present
    Philadelphia, Pa, Us
    The Monell Center is the world’s only independent, non-profit scientific institute dedicated to interdisciplinary basic research on the senses of taste and smell.
  • Coagulo Medical Technologies, Inc.
    Founding Board Member & Advisor
    Coagulo Medical Technologies, Inc. Jun 2018 - Jun 2024
    Coagulo is commercializing point-of-care technology developed at MIT and Harvard MedicalSchool, aimed at the $26B coagulation market. Proprietary blood diagnostics and healthcare analytics platform generate actionable clinical information to help clinicians treat healthcare’s most vulnerable patient populations.
  • The Wharton School
    Lecturer And Adjunct Faculty
    The Wharton School Jan 1996 - Jan 2023
    Philadelphia, Pa, Us
    Lecturer in Entrepreneurship. Adjunct faculty from 2000-2001.
  • Kinnos
    Chairman Of The Board
    Kinnos Aug 2019 - Dec 2022
    Initially developed by Columbia University students inspired to make a difference during the 2014 Ebola outbreak in West Africa, Highlight® was created to address the urgent need to improve disinfection application for both epidemic response and everyday use. Our goal is to empower people to disinfect surfaces with confidence and to provide society with peace of mind through disinfection you can see*.
  • Dropworks, Inc. (Acquired By Bio-Rad)
    Member, Board Of Directors
    Dropworks, Inc. (Acquired By Bio-Rad) Oct 2018 - Sep 2021
    Dropworks has created a fast, flexible, and easily automated platform for performing biological assays in self-contained flowing droplets. FluxPCR™, our first application, will become the de facto solution for DNA and RNA quantification, providing an easy, accurate, and cost-accessible platform for research and, in the future, diagnostic applications*.
  • Readcoor, Inc. (Acquired By 10X Genomics)
    Chairman & Ceo, Founder
    Readcoor, Inc. (Acquired By 10X Genomics) Jan 2016 - Jun 2019
    ReadCoor (http://readcoor.com) is leading the next generation of “omics” by delivering the first panomic spatial sequencing platform to the global audience of researchers, clinicians, pharma and diagnostics companies, and ultimately patients. It is accomplishing this with a fundamental new technology called FISSEQ -- Fluorescent In-situ Sequencing -- which simultaneously enables integration of high throughput next-gen sequencing, morphometric analysis, cellular location and three dimensional spatial imaging. This uniquely powerful tool is the first and only implementation of “In-situ Sequencing” and will revolutionize the next phase in understanding the transcriptome by facilitating vast new research opportunities and important clinical insight. ReadCoor will fulfill the mission with a comprehensive set of high quality services, systems and actionable information provided to research and healthcare communities worldwide.
  • Wyss Institute For Biologically Inspired Engineering
    Entrepreneur In Residence
    Wyss Institute For Biologically Inspired Engineering Jan 2016 - Oct 2016
    Boston, Ma, Us
    Developing startups into independently financed operating companies.
  • Excel Venture Management, Llc
    Executive In Residence
    Excel Venture Management, Llc Aug 2015 - Sep 2016
    Boston, Ma, Us
    Interim position between startups. Excel Venture Management builds companies that apply transformative life science technologies to solve problems in healthcare and beyond. The Excel investment portfolio is balanced across healthcare IT and services, pharmaceuticals, diagnostics, medical devices, and life science platforms.
  • Metamark Genetics (Acquired By Labcorp)
    President & Ceo
    Metamark Genetics (Acquired By Labcorp) Apr 2013 - Sep 2015
  • Hologic Gen-Probe (Holx)
    General Manager, Lifecodes (Acquired By Immucor)
    Hologic Gen-Probe (Holx) Apr 2011 - Mar 2013
    Ca, 92121, Us
    Successfully guided acquisition of company by Immucor (backed by TPG).
  • Sequenom
    Vice President And Head Of Commercial Operations, (Acquired By Labcorp)
    Sequenom Mar 2009 - Dec 2010
    Westborough, Massachusetts, Us
    Transitioned SensiGen acquisition and led commercialization of MaterniT21 test.
  • Sensigen Inc.
    President & Ceo, Co-Founder (Acquired By Sequenom)
    Sensigen Inc. 2006 - Feb 2009
    A development stage biotechnology company focused on gene-based molecular diagnostics. Acquired by Sequenom (SQNM) in 2009.

Shawn Marcell Skills

Biotechnology Commercialization Strategy Entrepreneurship Venture Capital Medical Devices Mergers And Acquisitions Start Ups Infectious Diseases Product Launch Management Pharmaceutical Industry Lifesciences Strategic Planning Cancer Cross Functional Team Leadership Healthcare Clinical Development R&d Immunology Oncology Technology Transfer Molecular Biology Drug Discovery Public Relations Genomics Fda Licensing Biochemistry Clinical Trials Business Strategy Corporate Development Organizational Development Clinical Research Hardware Diagnostics Genetics Sales Cell Biology Pcr Biopharmaceuticals Neuroscience Cell Culture Cell Bioinformatics Research Science Investor Relations Corporate Finance Regulatory Affairs Biomedical Engineering

Shawn Marcell Education Details

  • The George Washington University
    The George Washington University
    Economics

Frequently Asked Questions about Shawn Marcell

What company does Shawn Marcell work for?

Shawn Marcell works for Hansjorg Wyss Institute For Biologically Inspired Engineering, Harvard Universit

What is Shawn Marcell's role at the current company?

Shawn Marcell's current role is Visiting Scholar and Entrepreneur-in-Residence.

What is Shawn Marcell's email address?

Shawn Marcell's email address is sh****@****rus.bio

What is Shawn Marcell's direct phone number?

Shawn Marcell's direct phone number is +120358*****

What schools did Shawn Marcell attend?

Shawn Marcell attended The George Washington University.

What are some of Shawn Marcell's interests?

Shawn Marcell has interest in Torres Del Paine 2009, 4th Kyu Judo, Education, Aconcagua In 2011.

What skills is Shawn Marcell known for?

Shawn Marcell has skills like Biotechnology, Commercialization, Strategy, Entrepreneurship, Venture Capital, Medical Devices, Mergers And Acquisitions, Start Ups, Infectious Diseases, Product Launch, Management, Pharmaceutical Industry.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.